Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v8-EN
Language English English
Date Updated 2021-09-24 2021-09-23
Drug Identification Number 02246860 02246860
Brand name APO-FENO-SUPER APO-FENO-SUPER
Common or Proper name APO-FENO-SUPER APO-FENO-SUPER
Company Name AA PHARMA INC AA PHARMA INC
Ingredients FENOFIBRATE FENOFIBRATE
Strength(s) 160MG 160MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BTL 100BTL
ATC code C10AB C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-15 2021-09-15
Estimated end date 2021-09-29 2021-09-29
Actual end date 2021-09-23 2021-09-23
Shortage status Resolved Actual shortage
Company comments
Health Canada comments